Study Finds 31 Percent Use No Opioids After Surgery

This article originally appeared here.
Share this content:
Study Finds 31 Percent Use No Opioids After Surgery
Study Finds 31 Percent Use No Opioids After Surgery

FRIDAY, April 20, 2018 (HealthDay News) -- Almost 63 percent of patients did not use opioids after having an elective procedure, according to a study presented at the annual meeting of the American Surgical Association, held from April 19 to 21 in Phoenix.

Cornelius A. Thiels, D.O., from the Mayo Clinic in Rochester, Minn., and colleagues conducted a prospective survey of patients to investigate postoperative opioid use. In total, 2,550 patients undergoing 25 elective procedures were asked to complete a 29-question telephone interview survey 21 to 35 days after being discharged; 1,907 patients completed the survey.

The researchers found that 92.2 percent of patients received discharge opioids. These were converted into oral morphine equivalents (OMEs). After discharge, a median of 44 OMEs were consumed. On average, 62.7 percent of prescribed opioids were unused. Thirty-one percent of patients used no opioids, and 52.3 percent required <50 OMEs. The refill rates varied from 1.7 to 71.4 percent for laparoscopic inguinal hernia and lumbar fusion, respectively. Most patients (90.2 percent) were satisfied with their post-discharge pain control. More than one-quarter (28.2 percent) reported being prescribed too many opioids, while 8.3 percent reported not being prescribed enough. Remaining opioids were disposed of by only 7.5 percent of patients.

"This research provides a road map for physicians and surgical departments," a coauthor said in a statement. "It shows there are certain surgeries and types of patients who are likely receiving significantly more opioids than needed."

Abstract
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »